混合表型的急性髓性白血病的特征是RUNX1突变,茎状特征和有限的血统可塑性
medRxiv : the preprint server for health sciences
|November 14, 2023
概括
混合表型急性白血病 (AML-MP) 在临床和生物学上与其他急性骨髓性白血病 (AML) 相似,与混合表型急性白血病 (MPAL) 不同. AML-MP表现出独特的遗传特征,如RUNX1突变和茎状特征.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 混合表型 (MP) 急性白血病存在分类和管理方面的挑战.
- 世卫组织的分类将某些混合表型骨髓性白血病 (AML-MP) 排除在混合表型急性白血病 (MPAL) 之外.
- 有限的研究存在于AML-MP.的独特特征.
研究的目的:
- 研究AML-MP的临床,免疫类型,基因组和转录组特征.
- 为了将AML-MP与MPAL和没有混合表型的急性髓性白血病 (AML) 进行比较.
- 为了验证AML-MP被排除在MPAL诊断之外.
主要方法:
- 来自AML-MP,MPAL和AML队列的临床,免疫类型,基因组和转录组数据的综合分析.
- 基于免疫表型的无监督等级聚类.
- 转录组分析以识别分子签名.
- 对治疗反应和血统可塑性的比较.
主要成果:
- AML-MP与AML具有临床和遗传相似之处,但与MPAL有很大的不同.
- 与没有MP和MPAL的AML相比,RUNX1突变在AML-MP中更频繁.
- 转录组分析揭示了AML-MP和AML没有MP的干部特征的丰富,与MPAL不同.
- 与AML-MP不同的是,MPAL在治疗后经常表现出转换为仅淋巴细胞免疫类型的免疫类型,淋巴细胞分化因子上调.
结论:
- 在临床和生物学上,AML-MP更接近没有混合表型的AML,而不是MPAL.
- 这些发现支持当前的世卫组织分类建议,将AML-MP排除在MPAL之外.
- 需要进一步的研究,以了解AML中混合表型背后的分子机制.
相关概念视频
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K


